Perrigo | PRGO - Net Income



Perrigo reported $-8400000 in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
AbbVie USD 938M 348M Jun/2025
Abbott USD 1.78B 454M Jun/2025
Bayer EUR -199000000 1.5B Jun/2025
Bristol-Myers Squibb USD 1.31B 1.15B Jun/2025
Corcept Therapeutics USD 35.15M 14.6M Jun/2025
Dr.Reddys Laboratories INR 14.18B 1.69B Jun/2025
Eli Lilly USD 5.66B 2.9B Jun/2025
J&J USD 5.54B 5.46B Jun/2025
Merck USD 4.43B 652M Jun/2025
Nestle CHF 5.07B 175M Jun/2025
Pacira USD -4847000 9.66M Jun/2025
Perrigo USD -8400000 2M Jun/2025
Pfizer USD 2.91B 58M Jun/2025
Prestige Brands USD 61.78M 11.65M Jun/2025
Reckitt Benckiser GBP 284M 287M Dec/2024
Sanofi EUR 3.94B 2.07B Jun/2025
Supernus Pharmaceuticals USD 22.5M 34.33M Jun/2025
Teva Pharmaceutical Industries USD 282M 68M Jun/2025
Xeris Pharmaceuticals USD -1930000 52.91M Jun/2025
Zoetis USD 718M 87M Jun/2025